Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 6—June 2012
CME ACTIVITY - Research

Pretransplant Fecal Carriage of Extended-Spectrum β-Lactamase–producing Enterobacteriaceae and Infection after Liver Transplant, France

Frédéric BertComments to Author , Béatrice Larroque, Catherine Paugam-Burtz, Federica Dondero, François Durand, Estelle Marcon, Jacques Belghiti, Richard Moreau, and Marie-Hélène Nicolas-Chanoine
Author affiliations: Hôpital Beaujon, Clichy, France (F. Bert, B. Larroque, C. Paugam-Burtz, F. Dondero, F. Durand, E. Marcon, J. Belghiti, R. Moreau, M.H. Nicolas-Chanoine); Université Paris VII Faculté de Médecine D. Diderot, Paris, France (C. Paugam-Burtz, F. Durand, J. Belghiti, M.H. Nicolas-Chanoine); INSERM U 773 Centre de Recherche Biomédicale Bichat-Beaujon, CRB3, Paris (F. Durand, R. Moreau, M.H. Nicolas-Chanoine)

Main Article

Table 2

Temporal evolution of ESBLE pretransplant fecal carriage and posttransplant infection, France, by time period, January 2001–April 2010*

Variable No. (%) patients
 p value†
2001–2003, n = 185 2004–2006, n = 196 2007–2008, n = 188 2009–2010, n = 141
Pretransplant ESBLE fecal carriage 0 5 (2.5) 9 (4.8) 15 (10.6) <0.0001
Posttransplant ESBLE infection 3 (1.6) 9 (4.6) 9 (4.8) 18 (12.8) <0.0001

*ESBLE, extended spectrum β-lactamase–producing Enterobacteriaceae.
†Comparison among the 4 periods by test of trend.

Main Article

Page created: May 17, 2012
Page updated: May 17, 2012
Page reviewed: May 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external